Chemoinformaics analysis of 1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-phenylpropan-1-one
| Molecular Weight | 286.327 | nRot | 6 |
| Heavy Atom Molecular Weight | 268.183 | nRig | 13 |
| Exact Molecular Weight | 286.121 | nRing | 2 |
| Solubility: LogS | -4.583 | nHRing | 0 |
| Solubility: LogP | 3.533 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 43.6003 |
| nHD | 1 | BPOL | 22.3977 |
| QED | 0.828 |
| Synth | 1.89 |
| Natural Product Likeliness | 0.612 |
| NR-PPAR-gamma | 0.604 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.314 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.797 |
| MDCK | 0.0000193 |
| BBB | 0.578 |
| PPB | 0.95812 |
| VDSS | 0.513 |
| FU | 0.0184833 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.944 |
| CYP2c19-inh | 0.964 |
| CYP2c19-sub | 0.476 |
| CYP2c9-inh | 0.87 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.921 |
| CYP2d6-sub | 0.897 |
| CYP3a4-inh | 0.835 |
| CYP3a4-sub | 0.373 |
| CL | 10.444 |
| T12 | 0.493 |
| hERG | 0.103 |
| Ames | 0.223 |
| ROA | 0.109 |
| SkinSen | 0.699 |
| Carcinogencity | 0.194 |
| EI | 0.919 |
| Respiratory | 0.625 |
| NR-Aromatase | 0.063 |
| Antiviral | Yes |
| Prediction | 0.608565 |